Schedule 13G ownership disclosure
Fate Therapeutics Inc
Security class unavailable · CUSIP: 31189P102
Event date: 2023-04-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.2400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-23-000560
- Form type
- SC 13G
- Filer
- FATE THERAPEUTICS INC
- CIK
- CIK 1434316
- Filed
- May 10, 2023
- Reporting period
- Apr 30, 2023
- Description
- Schedule 13G beneficial ownership